Showing results (441-450 of 533) with videos related to
Sort By:
Pageof 54
The Lancet. Neurology|December 14, 2022
Comparison of amyloid burden in individuals with Down syndrome versus autosomal dominant Alzheimer's disease: a cross-sectional studyAnna H Boerwinkle, Brian A Gordon, Julie Wisch, et al.Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|January 9, 2020
Awareness of genetic risk in the Dominantly Inherited Alzheimer Network (DIAN)Andrew J Aschenbrenner, Bryan D James, Eric McDade, et al.Alzheimer'S & Dementia (Amsterdam, Netherlands)|November 9, 2022
Evaluation of dose-dependent treatment effects after mid-trial dose escalation in biomarker, clinical, and cognitive outcomes for gantenerumab or solanezumab in dominantly inherited Alzheimer's diseaseGuoqiao Wang, Yan Li, Chengjie Xiong, et al.Medrxiv : the Preprint Server for Health Sciences|March 27, 2026
OpenScientist: evaluating an open agentic AI co-scientist to accelerate biomedical discoveryKaleigh F Roberts, Zachary B Abrams, Luca Cappelletti, et al.Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|November 23, 2020
Dominantly inherited Alzheimer's disease in Latin America: Genetic heterogeneity and clinical phenotypesJorge J Llibre-Guerra, Yan Li, Ricardo F Allegri, et al.Neurobiology of Disease|March 31, 2022
CSF Tau phosphorylation at Thr205 is associated with loss of white matter integrity in autosomal dominant Alzheimer diseaseJeremy F Strain, Nicolas Barthelemy, Kanta Horie, et al.Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|October 25, 2025
Comparison of amyloid chronicity and EYO in autosomal dominant Alzheimer's diseaseJulie K Wisch, Nicole S McKay, Matthew Zammit, et al.The Lancet. Neurology|July 29, 2024
γ-Secretase activity, clinical features, and biomarkers of autosomal dominant Alzheimer's disease: cross-sectional and longitudinal analysis of the Dominantly Inherited Alzheimer Network observational study (DIAN-OBS)Stephanie A Schultz, Lei Liu, Aaron P Schultz, et al.Bioorganic & Medicinal Chemistry Letters|August 31, 2015
Development of a novel tricyclic class of potent and selective FIXa inhibitorsDongfang Meng, Patrick Andre, Thomas J Bateman, et al.Neurology|September 16, 2018
Longitudinal cognitive and biomarker changes in dominantly inherited Alzheimer diseaseEric McDade, Guoqiao Wang, Brian A Gordon, et al.Pageof 54